Financial News

Entrada Therapeutics, Inc. - Common Stock (NQ:TRDA)

7.580 -0.130 (-1.69%)
Streaming Delayed Price Updated: 2:14 PM EDT, Jun 30, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 170,074
Open 7.710
Bid (Size) 7.560 (400)
Ask (Size) 7.600 (400)
Prev. Close 7.710
Today's Range 7.450 - 7.750
52wk Range 4.930 - 16.45
Shares Outstanding 33,197,018
Dividend Yield N/A

Performance

YTD
-24.6%
-24.6%
1 Month
+9.7%
+9.7%
3 Month
-35.6%
-35.6%
6 Month
-25.9%
-25.9%
1 Year
+12.8%
+12.8%

More News

Read More

Frequently Asked Questions

Is Entrada Therapeutics, Inc. - Common Stock publicly traded?
Yes, Entrada Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Entrada Therapeutics, Inc. - Common Stock trade on?
Entrada Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Entrada Therapeutics, Inc. - Common Stock?
The ticker symbol for Entrada Therapeutics, Inc. - Common Stock is TRDA on the Nasdaq Stock Market
What is the current price of Entrada Therapeutics, Inc. - Common Stock?
The current price of Entrada Therapeutics, Inc. - Common Stock is 7.580
When was Entrada Therapeutics, Inc. - Common Stock last traded?
The last trade of Entrada Therapeutics, Inc. - Common Stock was at 06/30/26 02:14 PM ET
What is the market capitalization of Entrada Therapeutics, Inc. - Common Stock?
The market capitalization of Entrada Therapeutics, Inc. - Common Stock is 251.63M
How many shares of Entrada Therapeutics, Inc. - Common Stock are outstanding?
Entrada Therapeutics, Inc. - Common Stock has 252M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback